These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

811 related items for PubMed ID: 10769714

  • 1. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 2. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K, Sugimachi K.
    Cancer Res; 1993 Oct 15; 53(20):5000-3. PubMed ID: 8104690
    [Abstract] [Full Text] [Related]

  • 3. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
    Ebina M, Steinberg SM, Mulshine JL, Linnoila RI.
    Cancer Res; 1994 May 01; 54(9):2496-503. PubMed ID: 7909277
    [Abstract] [Full Text] [Related]

  • 4. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T, Uramoto H, Oyama T, Yashima Y, Gu C, Morita M, Sugio K, Kohno K, Yasumoto K.
    Anticancer Res; 2005 May 01; 25(5):3437-43. PubMed ID: 16101161
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 01; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 6. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
    Bellotti M, Elsner B, Paez De Lima A, Esteva H, Marchevsky AM.
    Mod Pathol; 1997 Dec 01; 10(12):1221-7. PubMed ID: 9436967
    [Abstract] [Full Text] [Related]

  • 7. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T, Sugai T, Nakamura S, Funato O, Nitta H, Sasaki R, Kanno S, Saito K.
    Cancer; 1998 Jan 01; 82(1):86-95. PubMed ID: 9428483
    [Abstract] [Full Text] [Related]

  • 8. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H, Yamashita Y, Takeda S, Miura K, Murata T, Kajiyama M.
    Fukuoka Igaku Zasshi; 1999 Jan 01; 90(1):6-13. PubMed ID: 10087668
    [Abstract] [Full Text] [Related]

  • 9. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM, Kisseberth WC, Obradovich JE, Moore FM, London CA, MacEwen EG, Ritter MA.
    Exp Hematol; 1996 Jun 01; 24(7):807-15. PubMed ID: 8647231
    [Abstract] [Full Text] [Related]

  • 10. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM, Reis MM, Palomino SA, Farhat C, Takagaki TY, Beyruti R, Saldiva PH, Capelozzi VL.
    Mod Pathol; 2000 May 01; 13(5):511-20. PubMed ID: 10824922
    [Abstract] [Full Text] [Related]

  • 11. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
    Bozcuk H, Gumus A, Ozbilim G, Sarper A, Kucukosmanoglu I, Ozbudak IH, Artac M, Ozdogan M, Samur M, Kaya A, Savas B.
    Med Sci Monit; 2005 Jun 01; 11(6):HY11-20. PubMed ID: 15917726
    [Abstract] [Full Text] [Related]

  • 12. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H, Shimabukuro T, Wada T, Yamamoto M, Shameem IA, Otsuka T, Sakano S, Matsuyama H, Naito K, Yamamoto N.
    Hinyokika Kiyo; 1993 Aug 01; 39(8):715-20. PubMed ID: 8104387
    [Abstract] [Full Text] [Related]

  • 13. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 01; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 14. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma.
    Törmänen U, Eerola AK, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto VP, Pääkkö P.
    Cancer Res; 1995 Dec 01; 55(23):5595-602. PubMed ID: 7585640
    [Abstract] [Full Text] [Related]

  • 15. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M, Koomägi R.
    Br J Cancer; 2000 May 01; 82(10):1747-54. PubMed ID: 10817513
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas.
    Mørkve O, Halvorsen OJ, Skjaerven R, Stangeland L, Gulsvik A, Laerum OD.
    Anticancer Res; 1993 May 01; 13(3):571-8. PubMed ID: 8391242
    [Abstract] [Full Text] [Related]

  • 17. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 01; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kühn R, Wittekind CW.
    Cancer; 1996 Jan 01; 77(1):164-71. PubMed ID: 8630925
    [Abstract] [Full Text] [Related]

  • 19. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
    Delahunt B, Bethwaite PB, Nacey JN, Ribas JL.
    J Pathol; 1993 Aug 01; 170(4):471-7. PubMed ID: 8105046
    [Abstract] [Full Text] [Related]

  • 20. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
    Mise K, Tashiro S, Yogita S, Wada D, Harada M, Fukuda Y, Miyake H, Isikawa M, Izumi K, Sano N.
    Clin Cancer Res; 1998 Jun 01; 4(6):1475-82. PubMed ID: 9626465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.